IMM
IMMUTEP FPO [IMM]
Healthcare · ASX Small Cap
$0.3800 -1.3%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +2First seen: 2026-02-25
Score Breakdown
Technical54
Catalyst50
Sentiment50
Fundamental71
Momentum63
Risk Gate40
Active Signals
Bullish Signals
- Bollinger squeeze (breakout building)
- Above 200-day MA (long-term uptrend)
- Adequate cash runway (6 quarters)
- 4C filed 2026-01-29
- Very high P/S ratio (70.6x)
- Strong revenue growth (+92%)
- CANSLIM I: Institutional ownership (44%)
- Strong revenue momentum (+92%)
- Days to cover very high (13.2)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2020-03)
Risk Signals
- Price below MAs (downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Yearly Report and Accounts
NONE Change in substantial holding
NONE Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC
LOW Immutep Quarterly Activities Report and Appendix 4C
Recent ASX Announcements
| 2026-02-24 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-10 | Change in substantial holding |
| 2026-02-05 | Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC PRICE SENSITIVE |
| 2026-02-04 | Change in substantial holding |
| 2026-01-29 | Immutep Quarterly Activities Report and Appendix 4C PRICE SENSITIVE |
Key Metrics
$559.3M
Market Cap
2.3M
Avg Volume
0.9x
Vol Ratio
$0.22 — $0.47
52-Week Range
2.1%
Short Interest
6 qtrs
Cash Runway
-61.8%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 83% |
| L | Leader vs Laggard | pass | RS: 10 |
| I | Institutional Sponsorship | pass | Inst: 44% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #5 of 119 · Sector avg: 51
View all Healthcare signals →